WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • WJPPS: MARCH ISSUE PUBLISHED
  • March Issue has been successfully launched on 1 March 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

Abstract

LITERARY REVIEW OF BIBHITAKA (TERMINALIA BELLIRICA. ROXB)

Dr. Arpita R. Kulkarni* and Dr. Apoorva M. Sangoram*

ABSTRACT

Bibhitaka is one of important ingredient of popular Ayurvedic formulation ‘Triphala choorna’. A well known plant which has been used for medicinal purpose regularly since vedic era. Part of Bibhitaka used mainly is fruit and seeds. Bibhitaka is well known for its astringent property and is used since ancient times for cough, sore throat, laryngitis, dyspepsia(internally) and for graying of hair(external application). Modern research shows Terminalia bellirica to be a powerful adaptogen. This review article covers review of Bibhitaka from vedic era, samhitas granthas, Nighantus till date.

Keywords: Ayurveda, Bibhitaka, Charak Samhita, Sushrut Samhita, Nighantu.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More